Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ZLNA.OL - Zelluna ASA
Q1 2026 Zelluna ASA Earnings Presentation
May 07, 2026 / 06:30AM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, and welcome to our first quarter 2026 business updates and financial results. I'm Nimeh Hassan, the CEO of Zaluna, and I'm delighted to be joined by Guy Christian, our CFO.
Can I have the next slide, please?
So today on the agenda, we will cover our key events in the first quarter of 2026.
The TCR-NK technology and pipeline, our first-in-human clinical trial, a financial update, and then end with a summary and outlook before we get on to questions and answers.
The next slide, please.
I'm delighted to share that we have had continued strong progress. Through Q1 2026. We announced in February the approval of our clinical trial application from the UK MHRA regulatory authorities and
Trustpilot
